SCHEMBL22365058

SCHEMBL22365058

C/C=C(\C=N/C)C(c1cccnc1)N1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.52
CYP3A5 P20815 3/20 0.52
GPR119 Q8TDV5 4/20 0.45
PLA2G7 Q13093 1/20 0.45
MGLL Q99685 1/20 0.45
ABHD6 Q9BV23 1/20 0.45
GLS O94925 1/20 0.43
GBA1 P04062 1/20 0.42
SLC1A2 P43004 1/20 0.41
POLB P06746 1/20 0.41
NAMPT P43490 1/20 0.40
KIT P10721 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
ALOX12 P18054 1/20 0.40
MPI P34949 1/20 0.40
ESR2 Q92731 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19668681 0.83 CYP3A4 (0.59) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL29363322 0.83 CYP3A4 (0.59) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL15093706 0.80 CYP3A4 (0.71) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL31071488 0.80 CYP3A4 (0.71) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL210120 0.79 CYP3A4 (0.61) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL14035283 0.78 CYP3A4 (0.58) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL20818634 0.78 CYP3A4 (0.58) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL30476445 0.78 CYP3A4 (0.58) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL8473516 0.74 CYP3A4 (0.53) CYP3A4CYP3A5GPR119PLA2G7MGLL
SCHEMBL8473520 0.74 CYP3A4 (0.53) CYP3A4CYP3A5GPR119PLA2G7MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3698782-A1 CARBAMATE COMPOUNDS FOR USE IN THERAPY Lundbeck La Jolla Research Center, Inc. (US) 2020-08-26 EP disclosed